Michael Celano Insider Trading $REPH Recro Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Celano.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Celano. Michael Celano is Director in ORASURE TECHNOLOGIES INC ($OSUR) and Chief Financial Officer in Larimar Therapeutics, Inc. ($ZFGN) and Chief Financial Officer in Recro Pharma, Inc. ($REPH) and Chief Operating Officer in Recro Pharma, Inc. ($REPH).
Michael Celano in Recro Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Celano: Chief Operating Officer, Chief Financial Officer
Holdings: 39,445 shares
Current Value: $317,532
Latest Transaction: Jan 23 2019
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael Celano in Recro Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LRMR, OSUR, REPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | M | 0.00 | 6,400 | 0 | 12,800 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | A | 7.99 | 60,592 | 484,130 | 60,592 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Payment of Exercise | F | 7.99 | 1,782 | 14,238 | 44,063 | 45.8 K to 44.1 K (-3.89 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Buy | M | 0.00 | 6,400 | 0 | 45,845 | 39.4 K to 45.8 K (+16.23 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Grant | A | 0.00 | 12,672 | 0 | 39,445 | 26.8 K to 39.4 K (+47.33 %) |
| Jan 04 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Payment of Exercise | F | 7.41 | 1,702 | 12,612 | 26,773 | 28.5 K to 26.8 K (-5.98 %) |
| Jan 22 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | M | 0.00 | 6,400 | 0 | 19,200 | |
| Jan 22 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Payment of Exercise | F | 8.89 | 2,020 | 17,958 | 28,475 | 30.5 K to 28.5 K (-6.62 %) |
| Jan 22 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Buy | M | 0.00 | 6,400 | 0 | 30,495 | 24.1 K to 30.5 K (+26.56 %) |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | A | 9.04 | 40,000 | 361,600 | 40,000 | |
| Jan 04 2018 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Grant | A | 0.00 | 20,000 | 0 | 24,095 | 4.1 K to 24.1 K (+488.40 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Payment of Exercise | F | 9.04 | 1,905 | 17,221 | 4,095 | 6 K to 4.1 K (-31.75 %) |
| Oct 02 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Buy | M | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Jan 20 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Option Exercise | A | 0.00 | 25,600 | 0 | 25,600 | |
| Jan 20 2017 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Option Exercise | A | 7.33 | 35,800 | 262,414 | 35,800 | |
| Jul 05 2016 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Financial Off ... | Option Exercise | A | 8.21 | 140,000 | 1,149,400 | 140,000 |
Page: 1